8:24AM On The Wires (WIRES) :Optimer Pharmaceuticals (OPTR) announced the implementation of an initiative designed to accelerate and expand patient access to DIFICID (fidaxomicin) tablets. Separately, co announced a new project analyzing the burden of Clostridium difficile infection.
Market Data 
Markets 
AI
